OTS167 treatment attenuated pulmonary hypertension, right ventricular hypertrophy, and pulmonary vascular remodeling in Su/H mice, supporting the therapeutic potential of targeting MELK signaling in PAH. The gene discussed is MELK; the disease is pulmonary hypertension.